Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies

Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to become the second leading cause of cancer-related deaths in the next decade. Despite 5-fluorouracil/leucovorin with irinotecan and oxaliplatin (FOLFIRINOX) and gemcitabine/nab-paclitaxel significantly improvin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiorean, Elena Gabriela, Coveler, Andrew L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500614/
https://www.ncbi.nlm.nih.gov/pubmed/26185420
http://dx.doi.org/10.2147/DDDT.S60328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500614/
https://www.ncbi.nlm.nih.gov/pubmed/26185420
http://dx.doi.org/10.2147/DDDT.S60328

Ejemplares similares